Basal Tumours in Bladder Cancer, Response to chemoTherapy

NCT04089748 · clinicaltrials.gov ↗

COMPLETED

Status

293

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Chemotherapy Effect

Interventions

COMBINATION_PRODUCT: neoadjuvant chemotherapy with cisplatine

Sponsor

University Hospital, Rouen

Collaborators

[object Object]
[object Object]